Claritev Return on Tangible Equity 2019-2025 | CTEV
Claritev Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2025-03-31 | $-1.18B | $-4.53B | 25.80% |
2024-12-31 | $-1.65B | $-4.55B | 35.77% |
2024-09-30 | $-1.54B | $-4.56B | 33.07% |
2024-06-30 | $-1.17B | $-4.61B | 24.87% |
2024-03-31 | $-0.63B | $-4.69B | 13.21% |
2023-12-31 | $-0.09B | $-4.75B | 1.90% |
2023-09-30 | $-0.71B | $-4.80B | 14.72% |
2023-06-30 | $-0.67B | $-4.87B | 13.70% |
2023-03-31 | $-0.62B | $-4.77B | 12.54% |
2022-12-31 | $-0.57B | $-4.86B | 11.41% |
2022-09-30 | $0.10B | $-4.96B | -2.01% |
2022-06-30 | $0.16B | $-5.07B | -3.08% |
2022-03-31 | $0.10B | $-5.17B | -1.87% |
2021-12-31 | $0.10B | $-5.30B | -1.88% |
2021-09-30 | $-0.10B | $-5.38B | 1.77% |
2021-06-30 | $-0.46B | $-5.49B | 12.12% |
2021-03-31 | $-0.47B | $-5.53B | 21.68% |
2020-12-31 | $-0.52B | $-5.28B | 99.47% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.650B | $0.931B |
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $46.427B | 59.33 |
Hims & Hers Health (HIMS) | United States | $12.608B | 131.00 |
Tempus AI (TEM) | United States | $10.745B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.683B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.012B | 62.68 |
Hinge Health (HNGE) | United States | $3.034B | 0.00 |
Privia Health (PRVA) | United States | $2.827B | 193.25 |
Enovis (ENOV) | United States | $1.816B | 10.12 |
Schrodinger (SDGR) | United States | $1.807B | 0.00 |
Phreesia (PHR) | United States | $1.595B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.555B | 0.00 |
Omnicell (OMCL) | United States | $1.452B | 25.62 |
Azenta (AZTA) | United States | $1.316B | 61.17 |
10x Genomics (TXG) | United States | $1.160B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.652B | 0.00 |
Butterfly Network (BFLY) | United States | $0.613B | 0.00 |
Talkspace (TALK) | United States | $0.550B | 164.50 |
Veradigm (MDRX) | United States | $0.476B | 0.00 |
Standard BioTools (LAB) | United States | $0.403B | 0.00 |
Outset Medical (OM) | United States | $0.371B | 0.00 |
TruBridge (TBRG) | United States | $0.358B | 794.00 |
Health Catalyst (HCAT) | United States | $0.285B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.261B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.142B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.128B | 0.00 |
Pulmonx (LUNG) | United States | $0.128B | 0.00 |
American Well (AMWL) | United States | $0.109B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
CareCloud (CCLD) | United States | $0.092B | 3.52 |
111 (YI) | China | $0.073B | 0.00 |
HeartBeam (BEAT) | United States | $0.056B | 0.00 |
P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.034B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.031B | 0.00 |
Zhongchao (ZCMD) | China | $0.027B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
Precipio (PRPO) | United States | $0.017B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |